Eli Lilly Considers $5.9 Billion Biomanufacturing Plant in Houston, Bringing Economic Growth and Jobs
Eli Lilly & Co. considers a $5.9 billion biomanufacturing plant in Houston’s Generation Park, potentially creating thousands of jobs and solidifying the city’s role in the biotechnology sector. Supported by substantial incentives, this project could reshape Houston’s economic landscape.